Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: | Fentanyl Sandoz |
Active Ingredient: | Fentanyl 2.1mg |
Dosage Form: | Transdermal patch |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Hexal AG, Holzkirchen, Germany |
Product: | Fentanyl Sandoz |
Active Ingredient: | Fentanyl 4.2mg |
Dosage Form: | Transdermal patch |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Hexal AG, Holzkirchen, Germany |
Product: | Fentanyl Sandoz |
Active Ingredient: | Fentanyl 6.3mg |
Dosage Form: | Transdermal patch |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Hexal AG, Holzkirchen, Germany |
Product: | Fentanyl Sandoz |
Active Ingredient: | Fentanyl 8.4mg |
Dosage Form: | Transdermal patch |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Hexal AG, Holzkirchen, Germany |
Product: | Fentanyl Sandoz |
Active Ingredient: | Fentanyl 12.6mg |
Dosage Form: | Transdermal patch |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Hexal AG, Holzkirchen, Germany |
Product: | Fentanyl Sandoz |
Active Ingredient: | Fentanyl 16.8mg |
Dosage Form: | Transdermal patch |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Hexal AG, Holzkirchen, Germany |
Dated this 16th day of May 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).